Wafik S. El-Deiry: Excellent opportunities for collaboration in developing novel therapeutic trials and precision oncology efforts
Wafik S. El-Deiry shared on LinkedIn: .
“Great to spend time with Dr. Naoto Ueno, Team Oncology and other colleagues including Dr. Michele Carbone, MD during visit and seminar presentation University of Hawai’i Cancer Center today. There are excellent opportunities for collaboration in developing novel therapeutic trials and precision oncology efforts.”
Source: Wafik S. El-Deiry/LinkedIn
Wafik El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals.
Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.
